Meet
Quotient


#glasslovers that transform blood diagnostics

#glasslovers that transform blood diagnostics
schott-microsites-nexterion-customer-case-quotient_blood-4500x3000-04062020_variant_640_1591275005569.png

Blood — The window to your health

Ed Farrell, COO at Swiss diagnostics company Quotient, has a clear mission: To create the world’s most efficient blood test.

As a SCHOTT customer, he shares with us how this goal drives him onward each and every day, and how specialty glass is helping him to achieve this goal.
schott-microsites-nexterion-customer-case-quotient_mosaiq-4500x3000-04062020_variant_640_1591271533169.jpg
Let me share with you why I put so much energy into my work and why I find glass to be so much more than a manufacturing material.

Ten years ago, I lost a family member to cancer. After that difficult time, I thought a lot about the cost of diagnostics testing and the current approach to testing – one test at a time.   I believed that with a different approach it could be possible to lower the cost and perform more tests at one to allow for early detection of different conditions.

I joined Quotient with the aim of changing the status quo.

Our vision is to make the world’s fastest, most reliable, and cost-efficient transfusion diagnostics tool a reality. We are developing systems that can identify diseases like HIV or hepatitis B without delay, and matching blood types between donors and recipients quickly and efficiently, all without medical practitioners having to worry about costs.

A single blood sample is all that is needed to produce meaningful health and diagnostic information.
schott-microsites-nexterion-customer-case-quotient_consumable-3840x2020_variant_640_1591273788409.jpg
That’s where MosaiQ comes in. MosaiQ is a diagnostic platform that automates blood group typing and antibody profiling. MosaiQ analyzes the blood sample using the red blood cells and antibodies we have printed onto glass microarrays. Each of these identical microarrays is as small as a fingernail and as thin as a human hair, yet each array offers space for 132 samples.

It is possible to achieve such precision within a small space because the microarrays are based on a transparent coated glass substrate (NEXTERION) to which blood cells and antibodies and antigens adhere. These substrates, or coated glass wafers, are provided by SCHOTT.
schott-microsites-nexterion-customer-case-quotient_meeting2-4500x3000-04062020_variant_640_1591272940981.jpg

A shared goal

We’ve worked closely with SCHOTT for many years now. If we were to lay all the NEXTERION glass wafers that we have processed during our relationship side by side, they would cover 20 tennis courts. And remember: A single glass on a microarray is barely the size of a fingernail!

It is through my work with SCHOTT that I have truly learned the sheer potential of glass and glass-derived products. I had previously worked with scientific glassware in diagnostics, but I had never given the glass itself any thought. Now, that has all changed.

Glass has helped make possibly one of the most innovative and efficient transfusion diagnostics platforms ever that offers the highest throughput and productivity per square meter lab space in today’s transfusion diagnostics setting. Through comprehensive analysis of blood samples, we will be able to supply better, more reliable test results. At the same time, we will provide relief from the ever-growing cost pressures labs in hospitals and blood donation centers encounter on an ongoing basis.
schott-microsites-nexterion-customer-case-quotient-4500x3000-04062020_variant_640_1591274868486.jpg
We want people all over the world to have access to the medical testing and diagnostic results they need—not just the ones they, or health authorities, can afford.

Glass can help us to make blood testing faster and more cost-effective while also ensuring reliable and reproducible results.

- Ed Farrell, COO at Quotient

Continue the journey